GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CDC25B, CDK6, CLK1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DYRK1A, DYRK1B, DYRK2, DYRK3, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HASPIN, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IGF1R, KDR, MAOA, MET, MMP1, MMP12, MMP2, MMP9, NISCH, PIM1, PPARA, PTPN1, PTPRS, SRC, TNKS, TNKS2, TYR, XDH |
10.9654 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TYR |
9.20849 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, ESR1, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
9.16258 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, APP, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, ESR1, FABP3, FABP4, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, MET, PPARA |
9.12362 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, AURKB, AXL, BCL2, CBR1, CDC25B, CDK6, CLK1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DYRK1A, DYRK1B, DYRK2, DYRK3, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HASPIN, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, NISCH, PIM1, PPARA, PTPN1, PTPRS, SRC, TNKS, TNKS2, TYR, XDH |
7.01795 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CDC25B, CDK6, CLK1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DYRK1A, DYRK1B, DYRK2, DYRK3, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, GBA2, HASPIN, HSD17B1, HSD17B2, IGF1R, KDR, MAOA, MET, MMP1, MMP2, PIM1, PPARA, PTPN1, PTPRS, SRC, TNKS, TNKS2, TYR, XDH |
7.01795 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, AURKB, AXL, BCL2, CBR1, CDC25B, CDK6, CLK1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DYRK1A, DYRK1B, DYRK2, DYRK3, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HASPIN, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IGF1R, KDR, MAOA, MET, MMP1, MMP12, MMP2, MMP9, NISCH, PIM1, PPARA, PTPN1, PTPRS, SRC, TNKS, TNKS2, TYR, XDH |
6.98423 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, CLK1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, IGF1R, KDR, MET, SRC |
6.9799 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, BCL2, CDC25B, CDK6, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, HASPIN, IGF1R, KDR, MET, PIM1, SRC, TNKS |
6.9799 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, CLK1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, IGF1R, KDR, MET, SRC |
6.9799 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX5, AOX1, APP, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, FUT7, GBA2, NISCH, PIM1, PPARA, TYR, XDH |
6.92014 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.5996 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, AKR1B1, APP, AURKB, AXL, BCL2, CA12, CA2, CA7, CDK6, CYP19A1, CYP1A1, CYP1B1, ESR1, F10, F3, FABP3, FABP4, FLT3, HRH1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, KDR, MAOA, MCL1, MET, NISCH, PPARA, SRC, TNKS, TNKS2, XDH |
6.3696 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, APP, AXL, BCL2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, HSD11B2, HSD17B2, IGF1R, MMP2, MMP9, PPARA, SRC, TYR |
6.3696 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALPL, APP, AXL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, FABP4, FLT3, HRH1, HSD11B2, HSD17B2, IGF1R, KDR, MCL1, MMP2, PPARA, SRC, TYR |
6.33952 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AXL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HSD11B2, HSD17B2, SRC, TYR |
6.27887 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
5.98795 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, ALPL, APP, AURKB, AXL, BCL2, CA2, CA9, CBR1, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DYRK1A, DYRK1B, DYRK3, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD17B2, KDR, MCL1, MET, MMP2, MMP9, PIM1, PPARA, PTPRS, SRC, TNKS2, TYR |
5.83138 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX5, AOX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HSD11B1, HSD11B2, HSD17B1, HSD17B2, MAOA, TYR, XDH |
5.81268 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, AKR1B1, APP, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DYRK1A, DYRK2, DYRK3, ESR1, ESR2, F10, F3, FLT3, HRH1, IGF1R, KDR, MCL1, MET, MMP12, MMP9, NISCH, PTPN1, PTPRS, SRC, TNKS, TNKS2, XDH |
5.77089 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, AKR1B1, APP, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DYRK1A, DYRK1B, DYRK2, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FLT3, HRH1, IGF1R, KDR, MCL1, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, SRC, TNKS, TNKS2, XDH |
5.76924 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, BCL2, CDC25B, CDK6, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, HASPIN, IGF1R, KDR, MET, PIM1, SRC, TNKS |
5.73458 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, AKR1B1, APP, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DYRK1A, DYRK2, DYRK3, ESR1, ESR2, F10, F3, FLT3, HRH1, IGF1R, KDR, MCL1, MET, MMP12, MMP9, NISCH, PTPN1, PTPRS, SRC, TNKS, TNKS2, XDH |
5.68132 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9 |
5.68132 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, APP, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FLT3, HRH1, HSD11B2, SRC, TYR |
5.50918 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, AKR1B1, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, F10, F3, FLT3, KDR, MCL1, MET, MMP12, MMP9, PTPN1, SRC, TNKS, TNKS2, XDH |
5.3389 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, AKR1B1, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, F10, F3, FLT3, KDR, MCL1, MET, MMP12, MMP9, PTPN1, SRC, TNKS, TNKS2, XDH |
5.33513 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, APP, BCL2, CA2, CA9, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HRH1, HSD11B2, IGF1R, MMP2, PPARA, SRC |
5.33513 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALPL, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, HASPIN, IGF1R, KDR, MET, PIM1, PTPN1, PTPRS, SRC, TNKS, XDH |
5.33513 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
5.28375 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, BCL2, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, F10, FLT3, HASPIN, IGF1R, KDR, MET, SRC, TNKS |
5.27834 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, ALPL, APP, AXL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, FABP4, FLT3, HRH1, HSD11B2, HSD17B2, IGF1R, KDR, MCL1, MMP2, MMP9, PPARA, SRC, TYR |
5.26298 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, AOX1, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CLK1, CSNK2A1, CYP1A1, CYP1A2, DYRK1A, DYRK1B, DYRK2, DYRK3, ESR1, F10, F3, FLT3, FUT7, GBA2, HASPIN, IGF1R, KDR, MAOA, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, PTPRS, SRC, TNKS, TNKS2, TYR, XDH |
5.18864 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALPL, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, HASPIN, IGF1R, KDR, MET, PIM1, PTPN1, PTPRS, SRC, TNKS, XDH |
5.02649 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, KDR, PPARA, PTPRS, SRC, TYR |
4.9588 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, AKR1B1, APP, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DYRK1A, DYRK1B, DYRK2, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, HRH1, IGF1R, KDR, MCL1, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, SRC, TNKS, TNKS2, XDH |
4.87092 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CLK1, CSNK2A1, DYRK1A, FLT3, IGF1R, KDR, PIM1, SRC |
4.85181 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, APP, BCL2, CDC25B, CDK6, CSNK2A1, CYP1B1, ESR1, ESRRA, F3, FABP3, FLT3, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1, SRC, XDH |
4.85082 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
4.81286 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, AKR1B1, APP, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DYRK1A, DYRK2, DYRK3, ESR1, F10, F3, FLT3, IGF1R, KDR, MCL1, MET, MMP9, PTPN1, SRC, XDH |
4.72587 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, ALPL, APP, AXL, BCL2, CA2, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DYRK1A, DYRK1B, ESR1, ESRRA, ESRRB, FLT3, GBA2, HSD11B1, HSD17B2, KDR, MCL1, MMP9, PIM1, PPARA, PTPRS, SRC, TYR |
4.71983 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
4.68413 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, BCL2, CA2, CA9, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HSD11B2, PPARA, SRC |
4.5391 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
4.53857 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, APP, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, FABP4, KDR, MMP9, SRC |
4.51758 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
4.50111 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
4.39439 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.24119 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DYRK3, ESR1, F3, FLT3, IGF1R, KDR, MCL1, MET, MMP9, PIM1, PPARA, PTPN1, SRC, XDH |
4.22121 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, APP, BCL2, CDK6, CYP19A1, CYP1B1, F10, F3, IGF1R, KDR, MET, MMP9, NISCH, SRC |
4.2057 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, DYRK3, IGF1R, KDR, MCL1, MET, MMP9, PIM1, PPARA, PTPN1, SRC |
4.17312 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, AKR1B1, APP, AXL, BCL2, CSNK2A1, CYP1B1, F10, F3, FLT3, KDR, MCL1, MET, MMP12, MMP9, PTPN1, SRC, TNKS, TNKS2, XDH |
4.12669 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, CBR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, FABP4, FUT7, GBA2, MET, PPARA |
4.11149 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DYRK3, ESR1, F3, FLT3, IGF1R, KDR, MCL1, MET, MMP9, PIM1, PTPN1, SRC, XDH |
4.11066 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AOX1, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, FABP3, FABP4, FUT7, GBA2, MAOA, MMP1, MMP12, MMP2, MMP9, SRC, XDH |
4.10188 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, APP, AXL, BCL2, CYP19A1, CYP1A2, CYP1B1, ESR1, ESRRB, F10, F3, FABP4, HRH1, HSD11B2, HSD17B2, IGF1R, MCL1, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, SRC, TNKS2, TYR |
4.08688 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, AKR1B1, APP, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, DYRK1A, DYRK2, DYRK3, ESR1, ESR2, ESRRA, F10, F3, FABP4, FLT3, IGF1R, KDR, MCL1, MET, MMP12, MMP2, MMP9, PPARA, PTPN1, PTPRS, SRC, TNKS, TNKS2, XDH |
4.02656 |
[BP] GO:0018107 |
peptidyl-threonine phosphorylation
|
BCL2, CLK1, CSNK2A1, DYRK1A, HASPIN, TNKS |
3.98993 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, DYRK3, IGF1R, KDR, MCL1, MET, MMP9, PIM1, PTPN1, SRC |
3.97222 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, APP, BCL2, CDK6, CYP19A1, CYP1B1, F10, F3, IGF1R, KDR, MET, MMP9, NISCH, SRC |
3.84514 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, APP, BCL2, CDK6, CYP19A1, CYP1B1, F10, F3, IGF1R, KDR, MET, MMP9, NISCH, SRC |
3.83559 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, APP, BCL2, CYP19A1, CYP1B1, F10, F3, IGF1R, KDR, MET, MMP9, NISCH, SRC |
3.83559 |
[BP] GO:0018210 |
peptidyl-threonine modification
|
BCL2, CLK1, CSNK2A1, DYRK1A, HASPIN, TNKS |
3.80833 |
[BP] GO:0019538 |
protein metabolic process
|
ACHE, ALPL, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, ESR1, F10, F3, FLT3, FUT7, HASPIN, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, PTPRS, SRC, TNKS, TNKS2 |
3.79255 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, APP, CDK6, CYP19A1, DYRK1A, DYRK3, ESR1, F3, FABP4, IGF1R, MCL1, MET, MMP12, MMP2, PPARA, PTPN1, PTPRS, SRC, XDH |
3.78051 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DYRK3, ESR1, F3, FLT3, IGF1R, KDR, MCL1, MMP9, PIM1, PTPN1, SRC, XDH |
3.60876 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, PPARA |
3.58006 |
[BP] GO:0010676 |
None
|
DYRK2, ESRRB, HRH1, PPARA, SRC |
3.57243 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, AKR1B1, APP, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DYRK1A, DYRK2, DYRK3, ESR1, ESR2, F10, F3, FLT3, IGF1R, KDR, MCL1, MET, MMP12, MMP9, PTPN1, PTPRS, SRC, TNKS, TNKS2, XDH |
3.57243 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, AKR1B1, APP, AXL, BCL2, CSNK2A1, CYP1B1, ESRRA, F10, F3, FABP4, FLT3, KDR, MCL1, MET, MMP12, MMP2, MMP9, PTPN1, SRC, TNKS, TNKS2, XDH |
3.55983 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
3.51655 |
[BP] GO:0009698 |
phenylpropanoid metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.49386 |
[BP] GO:0009804 |
coumarin metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.49386 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.49386 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, APP, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, DYRK1A, DYRK3, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, IGF1R, KDR, MCL1, MET, MMP12, MMP9, NISCH, PIM1, PPARA, PTPN1, PTPRS, SRC, TNKS, TNKS2, XDH |
3.48378 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
3.48337 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, AKR1B1, APP, AXL, BCL2, CYP1B1, F10, F3, FLT3, KDR, MCL1, MET, PTPN1, SRC, XDH |
3.46089 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, DYRK3, IGF1R, KDR, MCL1, MMP9, PIM1, PTPN1, SRC |
3.41816 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.4079 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, APP, BCL2, CYP19A1, CYP1A1, CYP1B1, GBA2, MAOA, TYR |
3.36007 |
[BP] GO:0034502 |
protein localization to chromosome
|
AURKB, ESR1, HASPIN, TNKS, TNKS2 |
3.36007 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
BCL2, DYRK1A, DYRK3, ESR1, IGF1R, MCL1, MET, MMP9, PTPN1, SRC, XDH |
3.35764 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, BCL2, CDC25B, CDK6, CSNK2A1, ESR1, F3, FLT3, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1 |
3.27011 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PIM1, PPARA, SRC |
3.22712 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, APP, AURKB, BCL2, CDC25B, DYRK1A, DYRK1B, DYRK2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, HRH1, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTPN1, SRC, TNKS, TNKS2, XDH |
3.22389 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALPL, APP, AXL, BCL2, CDK6, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, HRH1, IGF1R, KDR, MMP2, MMP9, SRC |
3.14971 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, BCL2, CDK6, CYP19A1, DYRK1A, DYRK3, ESR1, ESR2, IGF1R, MCL1, MET, MMP12, MMP9, PPARA, PTPN1, PTPRS, SRC, XDH |
3.1491 |
[BP] GO:0044267 |
cellular protein metabolic process
|
ALPL, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, ESR1, F10, FLT3, FUT7, HASPIN, IGF1R, KDR, MET, MMP1, MMP2, PIM1, PTPN1, PTPRS, SRC, TNKS, TNKS2 |
3.11558 |
[BP] GO:0045913 |
None
|
DYRK2, ESRRB, HRH1, PPARA, SRC |
3.09526 |
[BP] GO:0006464 |
cellular protein modification process
|
ALPL, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, ESR1, F10, FLT3, FUT7, HASPIN, IGF1R, KDR, MET, PIM1, PTPN1, PTPRS, SRC, TNKS, TNKS2 |
3.07094 |
[BP] GO:0036211 |
protein modification process
|
ALPL, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, ESR1, F10, FLT3, FUT7, HASPIN, IGF1R, KDR, MET, PIM1, PTPN1, PTPRS, SRC, TNKS, TNKS2 |
3.07094 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, CA2, CA7, NISCH |
3.06106 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.05586 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALPL, APP, AXL, BCL2, CDK6, CYP1A1, CYP1B1, ESR1, FABP4, FLT3, HRH1, IGF1R, KDR, MMP2, SRC |
3.03928 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4, GBA2 |
3.02427 |
[BP] GO:0010907 |
None
|
DYRK2, ESRRB, PPARA, SRC |
3.01909 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
2.99464 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, APP, AURKB, BCL2, CDC25B, CSNK2A1, DYRK1A, DYRK1B, DYRK2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, HRH1, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTPN1, SRC, TNKS, TNKS2, XDH |
2.98578 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, AKR1B1, APP, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, DYRK1A, DYRK2, DYRK3, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, IGF1R, KDR, MCL1, MET, MMP12, MMP9, NISCH, PIM1, PPARA, PTPN1, PTPRS, SRC, TNKS, TNKS2, XDH |
2.95799 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, SRC |
2.929 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, BCL2, CA2, CA7, CDK6, KDR, SRC, TNKS, TNKS2 |
2.9228 |
[BP] GO:0032787 |
None
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, GBA2, PPARA |
2.89404 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, BCL2, MET, MMP9, PPARA, SRC |
2.85412 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALPL, APP, AURKB, AXL, BCL2, CA2, CA9, CDK6, CYP1A1, CYP1A2, CYP1B1, DYRK2, ESR1, FABP4, FLT3, HRH1, IGF1R, KDR, MCL1, MMP2, MMP9, PTPN1, SRC |
2.84582 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, APP, AXL, BCL2, CA2, CA7, CDK6, CSNK2A1, CYP19A1, CYP1B1, DYRK2, F10, F3, IGF1R, KDR, MET, MMP12, MMP9, NISCH, PPARA, PTPN1, SRC |
2.84309 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, AKR1B1, ALPL, APP, AURKB, AXL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DYRK2, ESR1, ESRRA, F10, F3, FABP3, FABP4, FLT3, HRH1, HSD11B2, HSD17B2, IGF1R, KDR, MCL1, MMP12, MMP2, MMP9, PPARA, PTPN1, SRC, TYR |
2.81326 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, BCL2, DYRK1A, DYRK3, ESR1, ESR2, IGF1R, MCL1, MET, MMP12, MMP9, PTPN1, PTPRS, SRC, XDH |
2.79785 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, BCL2, DYRK1A, DYRK3, ESR1, ESR2, IGF1R, MCL1, MET, MMP12, MMP9, PTPN1, PTPRS, SRC, XDH |
2.78383 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.74581 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.74581 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, APP, AURKB, CSNK2A1, CYP1B1, ESR1, FABP4, IGF1R, MET, MMP9, PIM1, PPARA, PTPN1, SRC, TNKS |
2.67613 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.656 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, APP, AURKB, BCL2, CDC25B, CSNK2A1, DYRK1A, DYRK1B, DYRK2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTPN1, SRC, TNKS, TNKS2, XDH |
2.61324 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA |
2.58807 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AOX1, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, MAOA |
2.58755 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AURKB, BCL2, CLK1, CYP1A1, ESR1, FLT3, MET, PIM1, SRC, TYR |
2.53743 |
[BP] GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway
|
BCL2, MCL1, MMP9, PTPN1, SRC |
2.49606 |
[BP] GO:2000811 |
negative regulation of anoikis
|
BCL2, MCL1, SRC |
2.49509 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.49509 |
[BP] GO:0043412 |
macromolecule modification
|
ALPL, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, ESR1, F10, FLT3, FUT7, HASPIN, IGF1R, KDR, MET, PIM1, PTPN1, PTPRS, SRC, TNKS, TNKS2 |
2.44644 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, APP, AURKB, BCL2, CDC25B, CSNK2A1, DYRK1A, DYRK1B, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTPN1, SRC, TNKS, TNKS2, XDH |
2.44398 |
[BP] GO:0018105 |
peptidyl-serine phosphorylation
|
AURKB, BCL2, CLK1, DYRK1A, SRC, TNKS |
2.4263 |
[BP] GO:1904355 |
positive regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.42602 |
[BP] GO:0030335 |
positive regulation of cell migration
|
APP, BCL2, F10, F3, IGF1R, KDR, MET, MMP9, SRC |
2.42602 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, SRC |
2.4044 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, ALPL, APP, AXL, BCL2, CBR1, CDC25B, CDK6, CYP1A1, DYRK3, ESR1, ESRRB, FABP4, FLT3, FUT7, GBA2, KDR, MCL1, MET, MMP2, MMP9, PTPRS, SRC |
2.39359 |
[BP] GO:0051098 |
regulation of binding
|
APP, AURKB, BCL2, MET, MMP9, PPARA, SRC, TNKS |
2.39154 |
[BP] GO:0016137 |
None
|
AKR1B1, AKR1B10, GBA2 |
2.36139 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.33741 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.33741 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, APP, CYP1A1, CYP1B1, ESR1, FLT3, HRH1, SRC |
2.33741 |
[BP] GO:2000147 |
positive regulation of cell motility
|
APP, BCL2, F10, F3, IGF1R, KDR, MET, MMP9, SRC |
2.33232 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AXL, BCL2, CYP1B1, MMP9, SRC |
2.33089 |
[BP] GO:0032210 |
regulation of telomere maintenance via telomerase
|
AURKB, SRC, TNKS, TNKS2 |
2.32644 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CDC25B, CDK6, CLK1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DYRK1A, DYRK1B, DYRK2, DYRK3, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HASPIN, HRH1, HSD17B1, HSD17B2, IGF1R, KDR, MAOA, MCL1, MET, MMP1, MMP12, MMP2, MMP9, NISCH, PIM1, PPARA, PTPN1, PTPRS, SRC, TNKS, TNKS2, TYR, XDH |
2.32495 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, BCL2, CYP1A1, HSD11B2, MMP2, PPARA, SRC |
2.31594 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.31378 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, AXL, BCL2, CYP1B1, SRC |
2.29314 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, MMP9, SRC |
2.29314 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
APP, BCL2, F10, F3, IGF1R, KDR, MET, MMP9, SRC |
2.25878 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, BCL2, CYP1A1, HSD11B2, MMP2, PPARA, SRC |
2.25032 |
[BP] GO:0018209 |
peptidyl-serine modification
|
AURKB, BCL2, CLK1, DYRK1A, SRC, TNKS |
2.22486 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, GBA2, PIM1, PPARA, TYR |
2.21601 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, APP, AXL, BCL2, CA1, CSNK2A1, DYRK2, F3, FLT3, IGF1R, KDR, MCL1, MET, MMP2, MMP9, PTPN1, SRC, TNKS, TNKS2 |
2.20953 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, APP, AURKB, BCL2, CA2, CYP1A1, HRH1, HSD11B2, MMP2, PPARA, SRC, TYR |
2.20953 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
APP, AURKB, DYRK1B, DYRK2, ESR1, ESR2, ESRRA, ESRRB, FABP3, HRH1, IGF1R, KDR, MET, MMP12, PPARA, SRC, TNKS, TNKS2 |
2.20437 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, AXL, BCL2, CA9, CDK6, CYP1A1, CYP1B1, FABP3, HSD11B2, KDR, SRC |
2.16625 |
[BP] GO:0040017 |
positive regulation of locomotion
|
APP, BCL2, F10, F3, IGF1R, KDR, MET, MMP9, SRC |
2.16625 |
[BP] GO:1904356 |
regulation of telomere maintenance via telomere lengthening
|
AURKB, SRC, TNKS, TNKS2 |
2.15737 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.15528 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, AKR1B1, APP, AXL, BCL2, CA1, CA2, CDK6, CSNK2A1, CYP1B1, DYRK2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HASPIN, HRH1, IGF1R, KDR, MCL1, MET, MMP2, MMP9, NISCH, PIM1, PPARA, PTPN1, SRC, TNKS, TNKS2 |
2.1216 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, DYRK1A, ESR1, PPARA, SRC |
2.11455 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PTPN1, SRC |
2.11455 |
[BP] GO:2000209 |
regulation of anoikis
|
BCL2, MCL1, SRC |
2.11455 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.11455 |
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.11455 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.11455 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.11455 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
BCL2, DYRK1A, DYRK3, ESR1, ESR2, IGF1R, MCL1, MET, MMP12, MMP9, PTPN1, PTPRS, SRC, XDH |
2.11455 |
[BP] GO:0010675 |
None
|
DYRK2, ESRRB, HRH1, PPARA, SRC |
2.11455 |
[BP] GO:0006807 |
nitrogen compound metabolic process
|
ACHE, AKR1B1, AKR1B10, ALPL, AOX1, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CLK1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DYRK1A, DYRK1B, DYRK2, DYRK3, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FLT3, FUT7, GBA2, HASPIN, IGF1R, KDR, MAOA, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, PTPRS, SRC, TNKS, TNKS2, TYR, XDH |
2.09266 |
[BP] GO:2000573 |
positive regulation of DNA biosynthetic process
|
AURKB, SRC, TNKS, TNKS2 |
2.08105 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APP, FABP3, FLT3, HRH1, HSD11B2, IGF1R, MMP2, PPARA, SRC, TYR |
2.07872 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, ALPL, APP, AXL, BCL2, CDC25B, CYP19A1, CYP1A1, ESR1, ESRRB, HSD11B2, HSD17B2, MMP2, MMP9, SRC |
2.07872 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, BCL2, CYP1A1, HSD11B2, MMP2, PPARA, SRC |
2.07872 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.07872 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, AKR1B1, APP, AXL, BCL2, CA12, CA2, CA7, ESR1, FABP3, FABP4, FLT3, MCL1, MET, SRC |
2.06803 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.06653 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, AXL, BCL2, CYP1A1, CYP1B1, KDR, SRC |
2.02386 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, AOX1, APP, AURKB, BCL2, CA1, CA2, CA4, CA7, CBR1, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DYRK2, DYRK3, ESR1, ESR2, F10, FABP3, FABP4, FLT3, FUT7, GBA2, HRH1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, KDR, MAOA, MCL1, MMP2, MMP9, NISCH, PIM1, PTPN1, PTPRS, SRC, TNKS, TNKS2, TYR, XDH |
2.58988 |
[CC] GO:0043227 |
membrane-bounded organelle
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALPL, AOX1, APP, AURKB, AXL, BCL2, CA1, CA2, CA4, CBR1, CDK6, CLK1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DYRK1A, DYRK1B, DYRK2, DYRK3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HASPIN, IGF1R, KDR, MAOA, MCL1, MMP12, MMP2, MMP9, NISCH, PIM1, PPARA, PTPN1, PTPRS, SRC, TNKS, TNKS2, TYR, XDH |
2.38293 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
APP, BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, F10, FLT3, GBA2, HSD11B1, HSD11B2, HSD17B2, PTPN1 |
2.25802 |
[CC] GO:0031233 |
None
|
CA4, F10, F3 |
2.25784 |
[CC] GO:0097443 |
sorting endosome
|
KDR, PTPN1 |
1.80765 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, AOX1, APP, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DYRK2, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, TNKS, TYR, XDH |
14.7028 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CBR1, CDC25B, CDK6, CLK1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DYRK1A, DYRK1B, DYRK2, DYRK3, F10, F3, FLT3, FUT7, GBA2, HASPIN, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IGF1R, KDR, MAOA, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PTPN1, PTPRS, SRC, TNKS, TNKS2, TYR, XDH |
13.615 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, ALPL, AOX1, APP, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDK6, CLK1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DYRK1A, DYRK1B, DYRK2, DYRK3, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, HASPIN, HSD17B1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, NISCH, PIM1, PPARA, PTPN1, PTPRS, SRC, TNKS, TNKS2, TYR, XDH |
11.1469 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
9.78218 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, CLK1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, IGF1R, KDR, MET, SRC |
7.01795 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX5, AOX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HSD11B1, HSD11B2, HSD17B1, HSD17B2, MAOA, TYR, XDH |
6.9799 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
6.3696 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.01429 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CDK6, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, HASPIN, IGF1R, KDR, MET, PIM1, SRC |
6.00842 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, CBR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, XDH |
5.92553 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, PPARA, PTPN1, TNKS |
5.68132 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, XDH |
5.43895 |
[MF] GO:0004712 |
protein serine/threonine/tyrosine kinase activity
|
AURKB, CLK1, DYRK1A, DYRK1B, DYRK2, DYRK3 |
5.33513 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
5.302 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, ALPL, AOX1, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DYRK2, DYRK3, ESR1, ESR2, ESRRA, ESRRB, F10, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, TNKS, TNKS2, TYR, XDH |
5.23789 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CDK6, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, HASPIN, IGF1R, KDR, MET, PIM1, SRC |
5.16495 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13 |
5.12328 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CDK6, CLK1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, HASPIN, IGF1R, KDR, MET, PIM1, PPARA, SRC |
5.08309 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, ALPL, AOX1, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DYRK2, DYRK3, ESR1, ESR2, ESRRA, ESRRB, F10, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, TNKS, TNKS2, TYR, XDH |
4.9588 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TYR |
4.72587 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CDK6, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, HASPIN, IGF1R, KDR, MET, PIM1, SRC |
4.7235 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, CBR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
4.13588 |
[MF] GO:0140096 |
catalytic activity, acting on a protein
|
AURKB, AXL, CDC25B, CDK6, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, F10, F3, FLT3, HASPIN, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PTPN1, PTPRS, SRC |
4.02656 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, SRC |
3.97222 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CDK6, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, HASPIN, IGF1R, KDR, MET, PIM1, SRC |
3.88429 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13 |
3.83559 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, SRC |
3.79255 |
[MF] GO:0005496 |
steroid binding
|
ESR1, ESR2, ESRRA, ESRRB, HSD11B2, HSD17B1 |
3.79255 |
[MF] GO:0008289 |
lipid binding
|
AXL, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, HSD11B2, HSD17B1, NISCH, PPARA |
3.72719 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
3.68491 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
3.68491 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HSD11B2, HSD17B1, SRC, XDH |
3.57243 |
[MF] GO:0043168 |
anion binding
|
AOX1, APP, AURKB, AXL, CDK6, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, F10, F3, FABP3, FABP4, FLT3, HASPIN, HSD17B1, IGF1R, KDR, MET, NISCH, PIM1, PTPRS, SRC, XDH |
3.53209 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TYR |
3.51655 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
3.36007 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.31798 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.267 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.20697 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
3.10424 |
[MF] GO:0004674 |
protein serine/threonine kinase activity
|
AURKB, CDK6, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, HASPIN, PIM1 |
3.06847 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2A13, CYP2A6 |
2.9754 |
[MF] GO:0036094 |
small molecule binding
|
ADORA1, AOX1, AURKB, AXL, CDK6, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, FABP3, FABP4, FLT3, HASPIN, HSD11B2, HSD17B1, IGF1R, KDR, MET, PIM1, SRC, XDH |
2.88059 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
2.83683 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, CSNK2A1, ESRRB, FLT3, IGF1R, KDR, MMP12, MMP9, NISCH, PIM1, PPARA, PTPN1, SRC |
2.8203 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.74581 |
[MF] GO:0003845 |
None
|
HSD11B1, HSD11B2 |
2.74581 |
[MF] GO:0008389 |
None
|
CYP2A13, CYP2A6 |
2.74581 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
2.58807 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, ESRRB, FLT3, IGF1R, KDR, MMP12, MMP9, NISCH, PPARA, PTPN1, SRC |
2.47982 |
[MF] GO:0000166 |
nucleotide binding
|
AOX1, AURKB, AXL, CDK6, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, HASPIN, HSD11B2, HSD17B1, IGF1R, KDR, MET, PIM1, SRC, XDH |
2.34773 |
[MF] GO:1901265 |
nucleoside phosphate binding
|
AOX1, AURKB, AXL, CDK6, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, HASPIN, HSD11B2, HSD17B1, IGF1R, KDR, MET, PIM1, SRC, XDH |
2.34716 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, XDH |
2.29314 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, AOX1, APP, BCL2, CSNK2A1, DYRK1A, ESR1, ESR2, FLT3, IGF1R, KDR, MCL1, MET, MMP9, NISCH, TYR, XDH |
2.22833 |
[MF] GO:0005524 |
ATP binding
|
AURKB, AXL, CDK6, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, HASPIN, IGF1R, KDR, MET, PIM1, SRC |
2.19554 |
[MF] GO:0017171 |
serine hydrolase activity
|
ACHE, F10, F3, MMP1, MMP12, MMP2, MMP9 |
2.11903 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.11455 |
[MF] GO:0032559 |
adenyl ribonucleotide binding
|
AURKB, AXL, CDK6, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, HASPIN, IGF1R, KDR, MET, PIM1, SRC |
2.10911 |
[MF] GO:0030554 |
adenyl nucleotide binding
|
AURKB, AXL, CDK6, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, HASPIN, IGF1R, KDR, MET, PIM1, SRC |
2.08105 |